ProCE Banner Activity

Ending the HIV Epidemic: Persistence on ART

Podcast Episodes
Listen to Linda-Gail Bekker, MBChB, DTM&H, DCH, FCP(SA), PhD, discuss strategies for and importance of engaging and reengaging patients in their HIV care, and hear from a patient on how to persist on ART.

Released: October 04, 2022

Expiration: October 03, 2023

Share

Faculty

Nagalingeswaran Kumarasamy

Nagalingeswaran Kumarasamy, MBBS, FRCP, PhD

Chief & Director
VHS-Infectious Diseases Medical Centre
Director
Chennai Antiviral Research and Treatment (CART) Clinical Research Site
Voluntary Health Services
Chennai, India

Chloe Orkin

Chloe Orkin, MBChB, FRCP, MD

Professor of Infection and Inequities
Dean for Healthcare Transformation
Queen Mary University of London
Faculty of Medicine and Dentistry
London, United Kingdom

Babafemi Taiwo

Babafemi Taiwo, MBBS

Assistant Professor
Division of Infectious Diseases
Northwestern University Feinberg School of Medicine
Chicago, Illinois

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Gilead Sciences, Inc.

Faculty Disclosure

Primary Author

Nagalingeswaran Kumarasamy, MBBS, FRCP, PhD

Chief & Director
VHS-Infectious Diseases Medical Centre
Director
Chennai Antiviral Research and Treatment (CART) Clinical Research Site
Voluntary Health Services
Chennai, India

Nagalingeswaran Kumarasamy, MBBS, FRCP, PhD, has no relevant financial relationships to disclose.

Chloe Orkin, MBChB, FRCP, MD

Professor of Infection and Inequities
Dean for Healthcare Transformation
Queen Mary University of London
Faculty of Medicine and Dentistry
London, United Kingdom

Chloe Orkin, MBChB, FRCP, MD: consultant/advisor/speaker: Gilead Sciences, Janssen, MSD, ViiV Healthcare; researcher: Gilead Sciences, Janssen, MSD, ViiV Healthcare.

Babafemi Taiwo, MBBS

Assistant Professor
Division of Infectious Diseases
Northwestern University Feinberg School of Medicine
Chicago, Illinois

Babafemi Taiwo, MBBS: consultant/advisor/speaker: Gilead Sciences, GlaxoSmithKline, Johnson and Johnson, ViiV Healthcare.